Atrial fibrillation after thoracic surgery for lung cancer: use of a single cut-off value of N-terminal pro-B type natriuretic peptide to identify patients at risk

References

• ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). (2001). J Am Coll Cardiol 38:1231–65.
   PubMed Web of Science ®Google Scholar
• Amar D. (2002). Post-operative atrial fibrillation. Heart Dis 4:117–23.
   PubMedGoogle Scholar
• Amar D, Shi W, Hogue CW Jr, Zhang H, Passman RS, Thomas B, Bach PB, Damiano R, Thaler HT. (2004). Clinical prediction rule for atrial fibrillation after coronary artery bypass grafting. J Am Coll 44:1248–53.
   Web of Science ®Google Scholar
• Asamura H, Naruke T, Tsuchiya R, Goya T, Kondo H, Suemasu K. (1993). What are the risk factors for arrhythmias after thoracic operations? A retrospective multivariate analysis of 267 consecutive thoracic operations. J Thorac Cardiovasc Surg 106:1104–10.
   PubMed Web of Science ®Google Scholar
• Ascione R, Caputo M, Calori G, Lloyd CT, Underwood MJ, Angelini GD. (2000). Predictors of atrial fibrillation after conventional and beating heart coronary surgery: a prospective, randomized study. Circulation 102:1530–5.
   PubMed Web of Science ®Google Scholar
• Auer J, Weber T, Berent R, Ng CK, Lamm G, Eber B. (2005). Risk factors of postoperative atrial fibrillation after cardiac surgery. J Card Surg 20:425–31.
   PubMed Web of Science ®Google Scholar
• Brathwaite D, Weissman C. (1998). The new onset of atrial arrhythmias following major non-cardiothoracic surgery is associated with increased mortality. Chest 114:462–8.
   PubMed Web of Science ®Google Scholar
• Cardinale D, Martinoni A, Cipolla CM, Civelli M, Lamantia G, Fiorentini C, Mezzetti M. (1999). Atrial fibrillation after operation for lung cancer: clinical and prognostic significance. Ann Thorac Surg 68:1827–31.
   PubMed Web of Science ®Google Scholar
• Cardinale D, Colombo A, Sandri MT, Lamantia G, Colombo N, Civelli M, Salvatici M, Veronesi G, Veglia F, Fiorentini C, Spaggiari L, Cipolla CM. (2007). Increased perioperative N-terminal pro-B-type natriuretic peptide levels predict atrial fibrillation after thoracic surgery for lung cancer. Circulation 115:1339–44 .
   PubMed Web of Science ®Google Scholar
• Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Sutton GC. (1997). Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350:1349–53.
   PubMed Web of Science ®Google Scholar
• Coffin M, Sukhatme S. (1997). Receiver operating characteristic studies and measurement errors. Biometrics 53:823–37.
   PubMed Web of Science ®Google Scholar
• Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, Clopton P, Alberto J, Hlavin P, Maisel AS. (2001). Utility of B-type natriuretic peptide (BNP) in the diagnosis of CHF in an urgent care setting. J Am Coll Cardiol 37:379–85.
   PubMed Web of Science ®Google Scholar
• De Decker K, Jorens PG, Van Schil P. (2003). Cardiac complications after noncardiac thoracic surgery: an evidence-based current [Review]. Ann Thorac Surg 75:1340–8.
   PubMed Web of Science ®Google Scholar
• Dernellis J, Panaretou M. (2006). Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients. Heart 92:1645–50.
   PubMed Web of Science ®Google Scholar
• Ellinor PT, Low AF, Patton KK, Shea MA, MacRae CA. (2005). Discordant atrial natriuretic peptide and brain natriuretic levels in lone atrial fibrillation. J Am Coll Cardiol 45:82–8.
   PubMed Web of Science ®Google Scholar
• Goetze JP. (2004). Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited [Minireview]. Clin Chem 50:1503–10.
   PubMed Web of Science ®Google Scholar
• Hunt PJ, Richards AM, Nicholls NG, Yandle TG, Doughty RN, Espiner EA. (1997). Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-proBNP): a new marker of cardiac impairment. Clin Endocrinol 47:287–96.
   PubMed Web of Science ®Google Scholar
• Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, Clopton P, James C, Chiu A, Maisel AS. (2004). Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 43:1873–9.
   PubMed Web of Science ®Google Scholar
• Karthikeyan G, Moncur RA, Levine O, Heels-Ansdell D, Chan MT, Alonso-Coello P, Yusuf S, Sessler D, Villar JC, Berwanger O, McQueen M, Mathew A, Hill S, Gibson S, Berry C, Yeh HM, Devereaux PJ. (2009). Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol 54:1599–606.
   PubMed Web of Science ®Google Scholar
• Kerbaul F, Collart F, Giorgi R, Oddoze C, Lejeune PJ, Guidon C, Caus T, Bellezza M, Gouin F. (2004). Increased plasma levels of pro-brain natriuretic peptide in patients with cardiovascular complications following off-pump coronary artery surgery. Intensive Care Med 30:1799–806.
   PubMed Web of Science ®Google Scholar
• Lee SH, Jung JH, Choi SH, Lee N, Park WJ, Oh DJ, Rhim CY, Lee KH. (2006). Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circ J 70:100–4.
   PubMed Web of Science ®Google Scholar
• Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel AS. (2002). Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 105:595–601.
   PubMed Web of Science ®Google Scholar
• McKie PM, Burnett JC. (2005). B-type natriuretic peptide as a biomarker beyond heart failure: speculations and opportunities. Mayo Clinic Proc 80:1029–36.
   PubMed Web of Science ®Google Scholar
• Mohamed MK, Ramalingam S, Lin Y, Gooding W, Belani CP. (2005). Skin rash and good performance status predict improved survival with gefitinib in patients with advanced non-small cell lung cancer. Ann Oncol 16:780–5.
   PubMed Web of Science ®Google Scholar
• Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AP. (2004). Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350:647–54.
   PubMed Web of Science ®Google Scholar
• Ommen SR, Odell JA, Stanton MS. (1997). Atrial arrhythmias after cardiothoracic surgery [Review]. N Engl J Med 336:1429–34.
   PubMed Web of Science ®Google Scholar
• Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. (1982). Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–55.
   PubMed Web of Science ®Google Scholar
• Passman RS, Gingold DS, Amar D, Lloyd-Jones D, Bennett CL, Zhang H, Rusch VW. (2005). Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg 79:1698–703.
   PubMed Web of Science ®Google Scholar
• Patton KK, Ellinor PT, Heckbert SR, Christenson RH, DeFilippi C, Gottdiener JS, Kronmal RA. (2009). N-Terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation. Circulation 120:1768–74.
   PubMed Web of Science ®Google Scholar
• Roselli EE, Murthy SC, Rice TW, Houghtaling PL, Pierce CD, Karchmer DP, Blackstone EH. (2005). Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg 130:438–44.
   PubMed Web of Science ®Google Scholar
• Seino Y, Ogawa A, Yamashita T, Fukushima M, Ogata K, Fukumoto H, Takano T. (2004). Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for detection and evaluation of heart failure. Eur J Heart Fail 15:295–300.
   Google Scholar
• Struthers AD. (1994). Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use? [Review]. BMJ 308:1615–19.
   PubMed Web of Science ®Google Scholar
• Vaporciyan AA, Correa AM, Rice DC, Roth JA, Smythe WR, Swisher SG, Walsh GL, Putnam JB Jr. (2004). Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg 127:779–86.
   PubMed Web of Science ®Google Scholar
• Wazni OM, Martin DO, Marrouche NF, Latif AA, Ziada K, Shaaraoui M, Almahameed S, Schweikert RA, Saliba WI, Gillinov AM, Tang WH, Mills RM, Francis GS, Young JB, Natale A. (2004). Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 110:124–7.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfield MM. (1996). Superiority of brain natriuretic as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 28:988–94.
   PubMed Web of Science ®Google Scholar